IGM Biosciences (NASDAQ:IGMS) Wednesday reported that the company’s exclusive collaboration agreement with Sanofi (NASDAQ:SNY) to create and develop IgM agonist antibodies, will now focus exclusively ...
Source LinkIGM Biosciences (NASDAQ:IGMS) Wednesday reported that the company’s exclusive collaboration agreement with Sanofi (NASDAQ:SNY) to create and develop IgM agonist antibodies, will now focus exclusively ...
Source Link
Comments